How Mani was paid
$1.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Total |
|---|---|---|---|---|
| Surendra AjjarapuFormer Chairman of the Board, Chief Executive Officer, and Secretary | — | $100,000 | — | $100,000 |
| Prashant PatelFormer President, Chief Operating Officer, and Interim Principal Financial/ Accounting Officer | — | — | — | — |
| Dr. Narasimhan ManiCurrent Co-Chief Executive Officer, President, Interim Chief Financial Officer, and Director | $333,167 | — | $932,002 | $1,265,169 |
| Dr. Shankar HariharanCurrent Co-Chief Executive Officer, Executive Chairman, and Director | $233,167 | — | $932,002 | $1,165,169 |
| Eric SherbFormer Chief Financial Officer | $83,333 | — | $45,000 | $128,333 |
What changed and why
- $1.3M$1,265,169: Dr. Mani's 2025 total compensation, including $932,002 in stock awards.
- $1.2M$1,165,169: Dr. Hariharan's 2025 total compensation, including $932,002 in stock awards.
- May 20, 2025: Dr. Mani and Dr. Hariharan became co-chief executive officers.
- May 16, 2025: Surendra Ajjarapu resigned as chairman and chief executive officer.
- 99.7%99.7%: Votes cast supported the most recent say-on-pay proposal.
Other Scienture Holdings proxy statements
- 2025 proxy statement
Surendra Ajjarapu paid $570,577 (-9% on the year).
Filed Oct 24, 2025
About this page
The figures were read out of the DEF 14A proxy statement on EDGAR by a language model and every number was then checked against the filing text; a figure that could not be found there is left out rather than shown. Totals follow SEC rules, which value stock and option awards at grant. Read the filing for footnotes and the compensation committee's full reasoning.